Duzallo® (lesinurad/allopurinol) – New drug approval
August 21, 2017 – Ironwood Pharmaceuticals announced the FDA approval of Duzallo (lesinurad/allopurinol), for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a medically appropriate daily dose of allopurinol alone.
Top